Tennis Elbow

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 2415 Experts worldwide ranked by ideXlab platform

Hakan Alfredson - One of the best experts on this subject based on the ideXlab platform.

  • a two year sonographic follow up after intratendinous injection therapy in patients with Tennis Elbow
    British Journal of Sports Medicine, 2010
    Co-Authors: Eva Zeisig, Lars Ohberg, Martin Fahlstrom, Hakan Alfredson
    Abstract:

    Background Tennis Elbow is a tendinopathy affecting the upper extremity. Recent studies have shown high sensitivity for ultrasound (US) examination and high specificity for colour Doppler (CD) exam ...

  • pain relief after intratendinous injections in patients with Tennis Elbow results of a randomised study
    British Journal of Sports Medicine, 2008
    Co-Authors: Eva Zeisig, Lars Ohberg, Martin Fahlstrom, Hakan Alfredson
    Abstract:

    Pain relief after intratendinous injections in patients with Tennis Elbow : results of a randomised study

  • sclerosing polidocanol injections in chronic painful Tennis Elbow promising results in a pilot study
    Knee Surgery Sports Traumatology Arthroscopy, 2006
    Co-Authors: Eva Zeisig, Hakan Alfredson, Lars Ohberg
    Abstract:

    Sclerosing polidocanol injections targeting the area with neovessels (vascularity) have been demonstrated to give promising clinical results in patients with chronic painful Achilles and patellar tendinosis. Recently, we demonstrated vascularity in the extensor origin in patients with chronic painful Tennis Elbow, but not in controls with pain-free Elbows. In this pilot study, 11 patients (four men and seven women, mean age 46 years) with the diagnosis of Tennis Elbow in altogether 13 Elbows, were included. All patients had a long duration of pain symptoms (mean 23 months), and ultrasonography (US) + colour Doppler (CD) examination showed structural tendon changes with hypo-echoic areas, and a vascularity, corresponding to the painful area in the extensor origin. All patients were treated with US- and CD-guided injections of the sclerosing substance polidocanol, targeting the area with vascularity. At 8-month follow-up after treatment, there was a good clinical result in 11/13 Elbows. Extensor origin pain during wrist loading activities (recorded on a VAS-scale) was significantly reduced (mean VAS from 75 to 34; P < 0.003), and maximal grip strength was significantly increased (from 29 to 40 kg; P < 0.025). Our findings indicate that one treatment with sclerosing polidocanol injections, targeting the area with vascularity in the extensor origin, has a potential to reduce the tendon pain and increase grip strength, in patients with chronic painful Tennis Elbow.

  • extensor origin vascularity related to pain in patients with Tennis Elbow
    Knee Surgery Sports Traumatology Arthroscopy, 2006
    Co-Authors: Eva Zeisig, Lars Ohberg, Hakan Alfredson
    Abstract:

    Tennis Elbow, extensor carpi radialis brevis (ECRB) tendinosis, is a condition with unknown etiology and pathogenesis, known to be difficult to treat. The pain mechanisms have not been fully clarified, but involvement of a neurogenic inflammation mediated via the neuropeptide Substance-P (SP), has been suggested. In this investigation, grey-scale ultrasonography (US) and colour Doppler (CD) was used to examine the common extensor origin in 17 patients with the diagnose Tennis Elbow in altogether 22 Elbows, and in 11 controls with 22 pain-free Elbows. In 21/22 Elbows with chronic pain from the extensor origin, but only in 2/22 pain-free Elbows, vascularity was demonstrated in the extensor origin. After US and CD-guided injection of a local anaesthetic, targeting the area with vessels, the patients were pain-free during extensor-loading activity. The area with vascularity found in the extensor origin seems to be related to pain. Most likely, the findings correspond with the vasculo-neural in growth that has been demonstrated in the chronic painful Achilles tendon, and possibly have implications for treatment.

  • in vivo investigation of ecrb tendons with microdialysis technique no signs of inflammation but high amounts of glutamate in Tennis Elbow
    Acta Orthopaedica Scandinavica, 2000
    Co-Authors: Hakan Alfredson, Bjornove Ljung, Kim Thorsen, Ronny Lorentzon
    Abstract:

    We used the microdialysis technique to study concentrations of substances in the extensor carpi radialis brevis (ECRB) tendon in patients with Tennis Elbow. In 4 patients (mean age 41 years, 3 men) with a long duration of localized pain at the ECRB muscle origin, and in 4 controls (mean age 36 years, 2 men) with no history of Elbow pain, a standard microdialysis catheter was inserted into the ECRB tendon under local anesthesia. The local concentrations of the neurotransmitter glutamate and prostaglandin E2 (PGE2) were recorded under resting conditions. Samplings were done every 15 minutes during a 2-hour period. We found higher mean concentrations of glutamate in ECRB tendons from patients with Tennis Elbow than in tendons from controls (215 vs. 69 micromoL/L, p < 0.001). There were no significant differences in the mean concentrations of PGE2 (74 vs. 86 pg/mL). In conclusion, in situ microdialysis can be used to study certain metabolic events in the ECRB tendon of the Elbow. Our findings indicate involvement of the excitatory neurotransmitter glutamate, but no biochemical signs of inflammation (normal PGE2 levels) in ECRB tendons from patients with Tennis Elbow.

Mark I Johnson - One of the best experts on this subject based on the ideXlab platform.

Eva Zeisig - One of the best experts on this subject based on the ideXlab platform.

  • a two year sonographic follow up after intratendinous injection therapy in patients with Tennis Elbow
    British Journal of Sports Medicine, 2010
    Co-Authors: Eva Zeisig, Lars Ohberg, Martin Fahlstrom, Hakan Alfredson
    Abstract:

    Background Tennis Elbow is a tendinopathy affecting the upper extremity. Recent studies have shown high sensitivity for ultrasound (US) examination and high specificity for colour Doppler (CD) exam ...

  • pain relief after intratendinous injections in patients with Tennis Elbow results of a randomised study
    British Journal of Sports Medicine, 2008
    Co-Authors: Eva Zeisig, Lars Ohberg, Martin Fahlstrom, Hakan Alfredson
    Abstract:

    Pain relief after intratendinous injections in patients with Tennis Elbow : results of a randomised study

  • sclerosing polidocanol injections in chronic painful Tennis Elbow promising results in a pilot study
    Knee Surgery Sports Traumatology Arthroscopy, 2006
    Co-Authors: Eva Zeisig, Hakan Alfredson, Lars Ohberg
    Abstract:

    Sclerosing polidocanol injections targeting the area with neovessels (vascularity) have been demonstrated to give promising clinical results in patients with chronic painful Achilles and patellar tendinosis. Recently, we demonstrated vascularity in the extensor origin in patients with chronic painful Tennis Elbow, but not in controls with pain-free Elbows. In this pilot study, 11 patients (four men and seven women, mean age 46 years) with the diagnosis of Tennis Elbow in altogether 13 Elbows, were included. All patients had a long duration of pain symptoms (mean 23 months), and ultrasonography (US) + colour Doppler (CD) examination showed structural tendon changes with hypo-echoic areas, and a vascularity, corresponding to the painful area in the extensor origin. All patients were treated with US- and CD-guided injections of the sclerosing substance polidocanol, targeting the area with vascularity. At 8-month follow-up after treatment, there was a good clinical result in 11/13 Elbows. Extensor origin pain during wrist loading activities (recorded on a VAS-scale) was significantly reduced (mean VAS from 75 to 34; P < 0.003), and maximal grip strength was significantly increased (from 29 to 40 kg; P < 0.025). Our findings indicate that one treatment with sclerosing polidocanol injections, targeting the area with vascularity in the extensor origin, has a potential to reduce the tendon pain and increase grip strength, in patients with chronic painful Tennis Elbow.

  • extensor origin vascularity related to pain in patients with Tennis Elbow
    Knee Surgery Sports Traumatology Arthroscopy, 2006
    Co-Authors: Eva Zeisig, Lars Ohberg, Hakan Alfredson
    Abstract:

    Tennis Elbow, extensor carpi radialis brevis (ECRB) tendinosis, is a condition with unknown etiology and pathogenesis, known to be difficult to treat. The pain mechanisms have not been fully clarified, but involvement of a neurogenic inflammation mediated via the neuropeptide Substance-P (SP), has been suggested. In this investigation, grey-scale ultrasonography (US) and colour Doppler (CD) was used to examine the common extensor origin in 17 patients with the diagnose Tennis Elbow in altogether 22 Elbows, and in 11 controls with 22 pain-free Elbows. In 21/22 Elbows with chronic pain from the extensor origin, but only in 2/22 pain-free Elbows, vascularity was demonstrated in the extensor origin. After US and CD-guided injection of a local anaesthetic, targeting the area with vessels, the patients were pain-free during extensor-loading activity. The area with vascularity found in the extensor origin seems to be related to pain. Most likely, the findings correspond with the vasculo-neural in growth that has been demonstrated in the chronic painful Achilles tendon, and possibly have implications for treatment.

Dimitrios Stasinopoulos - One of the best experts on this subject based on the ideXlab platform.

R Burger - One of the best experts on this subject based on the ideXlab platform.

  • analgesic effect of extracorporeal shock wave therapy on chronic Tennis Elbow
    Journal of Bone and Joint Surgery-british Volume, 1996
    Co-Authors: J D Rompe, Ch Hopf, K Kullmer, J Heine, R Burger
    Abstract:

    We report a controlled, prospective study to investigate the effect of treatment by low-energy extracorporeal shock waves on pain in Tennis Elbow. We assigned at random 100 patients who had had symptoms for more than 12 months to two groups to receive low-energy shock-wave therapy. Group I received a total of 3000 impulses of 0.08 mJ/mm 2 and group II, the control group, 30 impulses. The patients were reviewed after 3, 6 and 24 weeks. There was significant alleviation of pain and improvement of function after treatment in group I in which there was a good or excellent outcome in 48% and an acceptable result in 42% at the final review, compared with 6% and 24%, respectively, in group II.

  • low energy extracorporal shock wave therapy for persistent Tennis Elbow
    International Orthopaedics, 1996
    Co-Authors: J D Rompe, Ch Hopf, K Kullmer, J Heine, R Burger, B Nafe
    Abstract:

    Fifty patients who suffered from persistent Tennis Elbow for more than 12 months, and were referred for surgical treatment, were assigned at random to 2 groups of low-energy extracorporal shock wave therapy. Group I received a total of 3000 impulses of 0.08 mJ/mm2; group II (controls) 30 impulses of 0.08 mJ/mm2. Follow up was after 3 and 12 weeks. We found no significant differences between the 2 groups before treatment, there was but significant relief of pain and improvement of function in group I with good or excellent outcome in 56% at the last evaluation.